Company / CapEx per Share
NovoCure Ltd CapEx per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.25
FY2025
5-year range
$0.21 / $0.40
FY2021-FY2025
Trend
-38.6%
vs FY2024
Sector context
#101 of 142
Health Care
What the data says
At $0.25, NovoCure Ltd's capex per share ranks #101 of 142 in the Health Care sector. CapEx per Share has fluctuated over the past 10 years, ranging from $0.07 in FY2016 to $0.40 in FY2024.
Based on SEC 10-K filings.
0.25 in FY2025 with a 5-year CAGR of +10.3%.
Declined from $0.26 to $0.25 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +6.1%
- 5-Year CAGR
- +10.3%
- 10-Year CAGR
- -
Sector benchmark
#101 of 142 in Health CareTop 71% of 142This company $0.25 Sector average $1.70
▼
-85.5% below sector average
Key checks
Key Insights
- In FY2025, capex per share decreased 38.6% year-over-year.
- Ranks #101 out of 142 companies in the Health Care sector.
- Peak capex per share was recorded in FY2024.
- Lowest capex per share in the period was in FY2016.
Company context
Key Data Points
- Altman Z-Score -0.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.25 | -38.6% |
| FY2024 | $0.40 | +55.2% |
| FY2023 | $0.26 | +25.5% |
| FY2022 | $0.21 | -13.0% |
| FY2021 | $0.24 | +57.1% |
| FY2020 | $0.15 | +33.8% |
| FY2019 | $0.11 | +49.9% |
| FY2018 | $0.08 | -11.3% |
| FY2017 | $0.08 | +24.9% |
| FY2016 | $0.07 | -80.5% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026